Longeveron Inc. fell 16.2% on Friday, November 13, 2026, on 60,400 shares. Headlines around the move:
Longeveron Inc. (LGVN:NASDAQ) closed at $1.82 on November 19, 2026, down 5.21% on the day. The stock trades 85.2% below its 52-week high of $12.30 and 38.9% above its 52-week low of $1.31. Over the past year, it lost 68.2%. Longeveron Inc. is part of the Health Care sector.
In 252 trading sessions since November 18, 2025, LGVN closed higher on 107 days (42%). Its best day was March 10, 2026 (+68.11%) and its worst was September 17, 2026 (-59.43%). The stock moved 10% or more in a single session 24 times. It opened at least 5% above the previous day's high 3 times.
Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS).
Find more stocks like LGVN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.